White Mark Andrew

White Mark Andrew is listed in filings as See Remarks at Rocket Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Nov 4, 2024, including sale activity. Recent filings connect the profile to Rocket Pharmaceuticals, Inc. (RCKT). The current snapshot covers public activity from Jul 9, 2024 to Nov 4, 2024. Reported amounts are shown as $51.2K to $61.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.